Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Asthma, Internal medicine, COPD, Immunology, and Allergy.
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Asthma and rhinitis control in adolescents and young adults: A real‐world <scp>MASK</scp> ‐air study
Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Back to the roots of medicine: It's severe asthma patient-reported symptoms that matter!
European Respiratory Society guidelines for the diagnosis of asthma in adults
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
How respiratory symptoms impact asthma-related quality of life in mild asthmatics
Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
Digital Health Europe (DHE) Twinning on severe asthma—kick-off meeting report
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Characteristics and treatment regimens across ERS SHARP severe asthma registries
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Collagen Degradation and Formation Are Elevated in Exacerbated COPD Compared With Stable Disease
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research